Capital Flow Monitor · Sponsors · CIK 1321834
TNF Pharmaceuticals, Inc.
1185 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036 · 856-848-8698
Pharmaceuticals · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$7.0M
Sold
$7.0M
% sold
100.0%
Investors
12
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-05 | D ·current | 506(b) | $7.0M | $7.0M | 100.0% | 12 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Ian Rhodes — Executive Officer, New York, NY
- Christopher Schreiber — Director, New York, NY
-
Joshua Silverman — Executive Officer / Director, New York, NY
2 other raises
- FEMASYS INC $30.0M of $30.0M · 100.0%
- Fabric.AI, Inc. $73.1M of $73.1M · 100.0%
-
Bruce Bernstein — Director, New York, NY
2 other raises
- XWELL, Inc. $31.0M of $31.0M · 100.0%
- WRAP TECHNOLOGIES, INC. $5.0M of $5.0M · 100.0%
- Bill J. White — Director, New York, NY
- Stephen Friscia — Director, New York, NY
- Mitchell Glass — Executive Officer / Director, New York, NY
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
- Gp Nurmenkari Inc. · 0 RE raises
- Rodman & Renshaw, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.